In line with this, IL-17 antibodies used for psoriasis treatment may trigger IBD or worsen bowel inflammation because IL-17 neutralization affects tissue homeostasis and the repairing process and also impairs intestinal wall integrity. The gene discussed is IL17A; the disease is inflammatory bowel disease.